CBIO Crescent Biopharma, Inc. - Common Stock

NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗
$17,40
Harga · Agu 19, 2026
Fundamental per Jul 30, 2026

CBIO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga
$17.39
Kapitalisasi Pasar
$480M
P/E (TTM)
-35.5
EPS (TTM)
$-0.59
Pendapatan (TTM)
$11M
Imbal Hasil Dividen
ROE
-90.0%
D/E Utang/Ekuitas
Rentang 52M
$9 – $27

CBIO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $11M
6-point trend, +58516.2%
2016-12-31 2025-12-31
EPS $-0.59
6-point trend, +56.0%
2019-12-31 2024-12-31
Arus Kas Bebas $-72M
10-point trend, -138.0%
2016-12-31 2025-12-31
Margin -1419.6%

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik
Tren 5 Tahun
CBIO
Median Rekan
P/E (TTM)
5-point trend, +79.3%
-35.5
19.6
P/S (TTM)
5-point trend, -98.3%
44.2
6.4
P/B
5-point trend, -98.3%
2.4
2.6
Price / FCF (Harga / FCF)
5-point trend, +96.6%
-6.6

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik
Tren 5 Tahun
CBIO
Median Rekan
Operating Margin (Margin Operasi)
5-point trend, -177.7%
-1407.5%
Net Profit Margin (Margin Laba Bersih)
5-point trend, -182.7%
-1419.6%
-104.2%
ROA
5-point trend, -108.7%
-111.6%
-40.3%
ROE
5-point trend, -26.3%
-90.0%
-42.4%
ROIC
-76.2%

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik
Tren 5 Tahun
CBIO
Median Rekan
Current Ratio (Rasio Lancar)
5-point trend, -14.6%
6.6
5.4
Quick Ratio (Rasio Cepat)
5-point trend, -16.0%
6.4

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik
Tren 5 Tahun
CBIO
Median Rekan
Revenue YoY (Pendapatan YoY)
5-point trend, +6.7%
-86.7%
Revenue CAGR 3Y (CAGR Pendapatan 3T)
5-point trend, +6.7%
424.9%
Revenue CAGR 5Y (CAGR Pendapatan 5T)
5-point trend, +6.7%
1.3%

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik
Tren 5 Tahun
CBIO
Median Rekan
EPS (Diluted)
5-point trend, +47.3%
$-0.59

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik
Tren 5 Tahun
CBIO
Median Rekan

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

Imbal Hasil Dividen
Rasio Pembayaran Dividen
CAGR Dividen 5T
Tanggal ex-dividenJumlah
13 Jan. 2023$24,0000
21 Sep. 2022$143,0000

CBIO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

BELI 15 analis
  • Beli Kuat 6 40,0%
  • Beli 7 46,7%
  • Tahan 2 13,3%
  • Jual 0 0,0%
  • Jual Kuat 0 0,0%

Target Harga 12 Bulan

5 analis · 2026-08-19
Target median $28.00 +61,0%
Target rata-rata $30.60 +75,9%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata
0.18%
Periode EPS Aktual EPS Estimasi Kejutan
30 Juni 2026 $-0.74 $-0.81 0.07%
31 Maret 2026 $-0.70 $-0.97 0.27%
31 Des. 2025 $-0.54 $-2.57 2.0%
30 Sep. 2025 $-1.27 $-2.02 0.75%
30 Juni 2025 $-4.93 $-1.80 -3.1%
31 Maret 2025 $-4.00 $-5.10 1.1%

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
CBIO $327M -24.2 -86.7% -1419.6% -90.0%
ALLO $314M -1.6 -76.8% -59.9%
GYRE $645M 353.0 10.2% 8.5% 11.7%
TECX $391M -5.2 -27.7%
SGMT -3.7 -42.3%
NVCT $194M -5.7 -149.9%
ASMB $539M -61.8 153.5% -8.5% -5.5%
MDXG $1.00B 21.2 20.0% 11.6% 20.5% 82.6%
SPRY $1.16B -6.7 -5.5% -203.3% -111.8%
ALT $400M -3.6 105.0% -214861.0% -45.6%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 14
Data Laporan Laba Rugi Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue 8-point trend, -27.8% $11M · $10.0K $75.0K $1M $10M · · · $18.5K $20M $15M
R&D Expense 12-point trend, +605.6% $138M $14M $20M $28M $47M $45M $47M $40M $24M $23M $25M $20M
SG&A Expense 12-point trend, +284.9% $25M $18M $19M $19M $17M $17M $14M $11M $10M $9M $8M $7M
Operating Expenses 12-point trend, +524.7% $163M $40M $39M $47M $65M $62M $61M $52M $34M $32M $33M $26M
Operating Income 12-point trend, -1270.1% $-153M $-40M $-39M $-47M $-63M $-52M $-61M $-52M $-34M $-32M $-13M $-11M
Other Non-op 6-point trend, +11742.7% · $2M $2M · · · · · $651.2K $103.6K $15.3K $18.2K
Pretax Income $-152M · · · · · · · · · · ·
Income Tax $2M · · · · · · · · · · ·
Net Income 12-point trend, -1284.2% $-154M $-38M $-37M $-47M $-63M $-51M $-58M $-48M $-33M $-32M $-13M $-11M
EPS (Basic) 7-point trend, +1.7% · $-0.59 $-0.58 $-0.89 $-1.23 $-1.12 $-1.34 · · · · $-0.60
EPS (Diluted) 7-point trend, +1.7% · $-0.59 $-0.58 $-0.89 $-1.23 $-1.12 $-1.34 · · · · $-0.60
Shares (Basic) 7-point trend, +249.4% · 64,477,249 63,342,465 52,531,173 51,453,204 45,721,139 43,254,782 · · · · 18,452,252
Shares (Diluted) 7-point trend, +249.4% · 64,477,249 63,342,465 52,531,173 51,453,204 45,721,139 43,254,782 · · · · 18,452,252
EBITDA 12-point trend, -1270.1% $-153M $-40M $-39M $-47M $-63M $-52M $-61M $-52M $-34M $-32M $-13M $-11M
Neraca 21
Data Neraca Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +286.2% $213M $35M $42M $48M $90M $137M $158M $210M $124M $40M $47M $55M
Receivables 2-point trend, +18000000.00 $18M $0 · · · · · · · · · ·
Prepaid Expense 12-point trend, +496.2% $5M $38.0K $2M $3M $533.8K $1M $4M $2M $3M $478.5K $441.8K $916.2K
Other Current Assets 2-point trend, +14276.3% $5M $38.0K · · · · · · · · · ·
Current Assets 12-point trend, +321.7% $237M $35M $44M $51M $91M $138M $163M $212M $127M $41M $47M $56M
PP&E (Net) 11-point trend, +87.1% $846.0K $0 · $242.4K $368.8K $620.7K $822.9K $957.2K $1M $1M $521.4K $452.3K
PP&E (Gross) 9-point trend, +93.6% · · · $3M $3M $3M $3M $3M $2M $2M $1M $1M
Accum. Depreciation 9-point trend, +163.6% · · · $2M $2M $2M $2M $2M $1M $1M $902.1K $905.5K
Other Non-current Assets 2-point trend, +49.6% $1M $813.0K · · · · · · · · · ·
Total Assets 12-point trend, +319.6% $240M $36M $45M $52M $94M $143M $168M $215M $129M $42M $48M $57M
Accounts Payable 11-point trend, -62.3% · $329.3K $868.1K $970.2K $2M $2M $1M $3M $3M $2M $564.2K $874.0K
Accrued Liabilities 12-point trend, +245.1% $16M $2M $5M $7M $9M $9M $9M $6M $4M $3M $6M $5M
Current Liabilities 12-point trend, +458.3% $36M $10M $7M $9M $12M $12M $11M $9M $8M $6M $8M $6M
Capital Leases 6-point trend, -57.1% $1M $0 $66.8K · $918.6K $2M $3M · · · · ·
Total Liabilities 12-point trend, +477.1% $37M $47M $7M $9M $13M $15M $14M $9M $9M $7M $8M $6M
Common Stock 12-point trend, +47.8% $28.0K $1.0K $64.4K $54.4K $52.3K $49.0K $43.5K $43.2K $34.4K $23.2K $19.0K $18.9K
Paid-in Capital 12-point trend, +196.2% $371M $2M $495M $462M $454M $438M $413M $406M $272M $154M $128M $125M
Retained Earnings 12-point trend, -130.9% $-172M $-18M $-456M $-420M $-373M $-309M $-258M $-201M $-152M $-119M $-87M $-74M
Stockholders' Equity 12-point trend, +299.6% $203M $-15M $38M $43M $82M $128M $154M $205M $120M $35M $40M $51M
Liabilities + Equity 12-point trend, +319.6% $240M $36M $45M $52M $94M $143M $168M $215M $129M $42M $48M $57M
Shares Outstanding 12-point trend, +45.5% 27,556,767 1,018,604 64,393,744 54,377,798 52,313,894 49,017,622 43,466,933 43,160,751 34,359,799 23,250,023 19,050,204 18,939,838
Arus Kas 11
Data Arus Kas Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Stock-based Comp 12-point trend, +713.4% $13M $5M $4M $4M $6M $7M $6M $5M $4M $3M $2M $2M
Deferred Tax $0 · · · · · · · · · · ·
Restructuring · $7M · · · · · · · · · ·
Operating Cash Flow 12-point trend, -1570.7% $-72M $-31M $-35M $-46M $-57M $-39M $-52M $-43M $-30M $-30M $-8M $-4M
CapEx 12-point trend, +332.3% $919.0K $10.0K $21.4K $84.2K $14.9K $68.5K $144.9K $125.6K $294.1K $704.2K $268.6K $212.6K
Investing Cash Flow 11-point trend, -27048.4% $-73M $20.0K $-21.4K $-84.2K $-14.9K $-68.5K $-144.9K $-125.6K $-294.1K $-704.2K $-268.6K ·
Stock Issued 9-point trend, -100.0% $0 · $29M $4M $11M $18M · $128M $114M $24M · $57M
Net Stock Activity 9-point trend, -100.0% $0 · $29M $4M $11M $18M · $128M $114M $24M · $57M
Financing Cash Flow 11-point trend, +282918.9% $323M $5.4K $29M $4M $11M $18M $412.9K $129M $114M $24M $114.1K ·
Net Change in Cash 12-point trend, +237.6% $179M $-31M $-6M $-42M $-47M $-21M $-52M $86M $84M $-7M $-8M $53M
Free Cash Flow 12-point trend, -1512.1% $-72M $-31M $-35M $-47M $-58M $-39M $-52M $-43M $-30M $-30M $-9M $-4M
Profitabilitas 7
Data Profitabilitas Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Operating Margin 8-point trend, -1798.7% -1407.5% · -392752.9% -63204.4% -5470.7% -506.8% · · · -172505.3% -63.7% -74.1%
Net Margin 8-point trend, -1818.1% -1419.6% · -368994.2% -62251.7% -5469.0% -502.1% · · · -171945.1% -63.6% -74.0%
Pretax Margin -1401.2% · · · · · · · · · · ·
EBITDA Margin 8-point trend, -1798.7% -1407.5% · -392752.9% -63204.4% -5470.7% -506.8% · · · -172505.3% -63.7% -74.1%
ROA 12-point trend, -213.8% -111.6% -134.3% -76.0% -63.9% -53.5% -32.8% -30.2% -28.1% -38.9% -70.0% -24.2% -35.6%
ROE 12-point trend, -117.2% -90.0% -1888.5% -86.9% -102.6% -71.2% -38.3% -36.0% -22.8% -42.9% -84.0% -28.0% -41.4%
ROIC -76.2% · · · · · · · · · · ·
Likuiditas & Solvabilitas 2
Data Likuiditas & Solvabilitas Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -24.5% 6.6 1.9 6.4 5.7 7.7 11.1 14.8 24.2 15.6 6.4 6.1 8.7
Quick Ratio 12-point trend, -25.0% 6.4 1.9 6.1 5.4 7.6 11.0 14.4 24.0 15.2 6.3 6.0 8.5
Efisiensi 2
Data Efisiensi Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Asset Turnover 8-point trend, -83.6% 0.1 · 0.0 0.0 0.0 0.1 · · · 0.0 0.4 0.5
Receivables Turnover 1.2 · · · · · · · · · · ·
Per Saham 5
Data Per Saham Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +174.6% $7.37 $0.08 $0.60 $0.79 $1.56 $2.62 $3.55 $4.76 $3.48 $1.52 $2.12 $2.68
Revenue / Share 4-point trend, -100.0% · · $0.00 $0.00 $0.02 · · · · · · $0.81
Cash Flow / Share 5-point trend, -107.9% · $-0.48 $-0.55 $-0.88 $-1.12 · · · · · · $-0.23
Cash / Share 12-point trend, +165.5% $7.74 $0.17 $0.65 $0.88 $1.73 $2.80 $3.64 $4.86 $3.61 $1.72 $2.46 $2.91
EPS (TTM) 12-point trend, +18.3% $-0.49 $-0.59 $-0.58 $-0.89 $-1.23 $-1.12 $-1.34 $-0.75 $-0.75 $-0.75 $-0.71 $-0.60
Tingkat Pertumbuhan 3
Data Tingkat Pertumbuhan Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue YoY 3-point trend, +2.2% · · -86.7% -93.5% -88.6% · · · · · · ·
Revenue CAGR 3Y 2-point trend, +571.8% 424.9% · -90.0% · · · · · · · · ·
Revenue CAGR 5Y 1.3% · · · · · · · · · · ·
Valuasi (TTM) 10
Data Valuasi (TTM) Tahunan untuk CBIO
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue TTM 8-point trend, -27.8% $11M · $10.0K $75.0K $1M $10M · · · $18.5K $20M $15M
Net Income TTM 12-point trend, -1284.2% $-154M $-38M $-37M $-47M $-63M $-51M $-58M $-48M $-33M $-32M $-13M $-11M
Market Cap 12-point trend, -97.6% $327M $1.61B $15.20B $16.48B $7.53B $18.43B $22.99B $40.87B $57.69B $14.18B $10.90B $13.64B
P/E 12-point trend, +98.0% -24.2 -42.4 -406.9 -340.4 -117.1 -335.7 -394.8 -1262.7 -2238.7 -813.3 -805.6 -1200.0
P/S 8-point trend, -96.7% 30.1 · 1519692.4 219686.3 6495.4 1813.5 · · · 766622.4 542.9 907.5
P/B 12-point trend, -99.4% 1.6 303.4 395.6 383.8 92.3 143.7 149.1 198.9 481.9 401.8 269.2 268.4
P / Tangible Book 5-point trend, -98.9% 1.6 · 395.6 383.8 92.3 143.7 · · · · · ·
P / Cash Flow 12-point trend, +99.9% -4.6 -51.8 -435.7 -354.7 -131.0 -469.7 -442.3 -943.3 -1938.0 -477.0 -1322.1 -3185.0
P / FCF 12-point trend, +99.9% -4.5 -51.8 -435.4 -354.0 -131.0 -468.8 -441.1 -940.5 -1919.0 -466.0 -1280.4 -3034.3
Earnings Yield 12-point trend, -5062.5% -4.1% -2.4% -0.25% -0.29% -0.85% -0.30% -0.25% -0.08% -0.04% -0.12% -0.12% -0.08%

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi
2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $11M$10.0K$75.0K$1M
Margin Operasi % -1407.5%-392752.9%-63204.4%-5470.7%
Laba Bersih $-154M$-38M$-37M$-47M$-63M
EPS Dilusian $-0.59$-0.58$-0.89$-1.23
Neraca
2025-12-312024-12-312023-12-312022-12-312021-12-31
Rasio Lancar 6.61.96.45.77.7
Rasio Cepat 6.41.96.15.47.6
Arus Kas
2025-12-312024-12-312023-12-312022-12-312021-12-31
Arus Kas Bebas $-72M$-31M$-35M$-47M$-58M

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Pemilik institusional (13F) 82 pengaju · $470.5M total · Per tanggal 30 Juni 2026

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
35 (+21 vs Kuartal sebelumnya) 12 (+2 vs Kuartal sebelumnya) 14 (-3 vs Kuartal sebelumnya) 15 (+7 vs Kuartal sebelumnya) +3.5M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
FMR LLC $51.011.496 2.833.972 10,84% Saham
BVF INC/IL $49.477.734 2.748.763 10,52% Saham
Fairmount Funds Management LLC $49.461.588 2.747.866 10,51% Saham
Venrock Adviser, LLC $38.404.368 2.133.576 8,16% Saham
Logos Global Management LP $34.200.000 1.900.000 7,27% Saham
FCPM III SERVICES B.V. $30.201.336 1.677.852 6,42% Saham
Balyasny Asset Management L.P. $29.932.506 1.662.917 6,36% Saham
Vestal Point Capital, LP $29.340.000 1.630.000 6,24% Saham
Opaleye Management Inc. $23.748.318 1.319.351 5,05% Saham
TANG CAPITAL MANAGEMENT LLC $20.880.000 1.160.000 4,44% Saham
VANGUARD CAPITAL MANAGEMENT LLC $13.819.590 767.755 2,94% Saham
MILLENNIUM MANAGEMENT LLC $7.269.462 403.859 1,55% Saham
JENNISON ASSOCIATES LLC $6.813.126 378.507 1,45% Saham
RTW INVESTMENTS, LP $6.711.408 372.856 1,43% Saham
NEXTBio Capital Management LP $6.711.408 372.856 1,43% Saham
Remedium Capital Partners, LLC $6.502.500 361.250 1,38% Saham
GEODE CAPITAL MANAGEMENT, LLC $6.056.873 336.411 1,29% Saham
VANGUARD GROUP INC $5.984.722 504.614 1,27% Saham
STATE STREET CORP $5.680.566 315.587 1,21% Saham
AMERIPRISE FINANCIAL INC $5.446.224 302.568 1,16% Saham
Point72 Asset Management, L.P. $5.400.000 300.000 1,15% Saham
PERCEPTIVE ADVISORS LLC $3.724.956 206.942 0,79% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $3.398.454 188.803 0,72% Saham
TWO SIGMA INVESTMENTS, LP $3.363.732 186.874 0,71% Saham
STEMPOINT CAPITAL LP $3.282.876 182.382 0,70% Saham
UBS Group AG $3.061.674 170.093 0,65% Saham
Exome Asset Management LLC $2.299.842 127.769 0,49% Saham
SECTORAL ASSET MANAGEMENT INC $2.183.400 121.300 0,46% Saham
Woodline Partners LP $1.700.784 94.488 0,36% Saham
VANGUARD FIDUCIARY TRUST CO $1.354.050 75.225 0,29% Saham
Burkehill Global Management, LP $1.332.000 74.000 0,28% Saham
Blackstone Inc. $1.127.646 62.647 0,24% Saham
SILVERARC CAPITAL MANAGEMENT, LLC $1.063.872 59.104 0,23% Saham
Y-Intercept (Hong Kong) Ltd $914.832 50.824 0,19% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $904.644 50.258 0,19% Saham
Nuveen, LLC $857.322 47.629 0,18% Saham
Stonepine Capital Management, LLC $720.000 40.000 0,15% Saham
RHUMBLINE ADVISERS $458.766 25.487 0,10% Saham
MOORE CAPITAL MANAGEMENT, LP $450.000 25.000 0,10% Saham
Squarepoint Ops LLC $434.988 24.166 0,09% Saham
AMERICAN CENTURY COMPANIES INC $410.490 22.805 0,09% Saham
TWO SIGMA ADVISERS, LP $385.450 32.500 0,08% Saham
WELLS FARGO & COMPANY/MN $354.600 19.700 0,08% Saham
ADAR1 Capital Management, LLC $328.950 18.275 0,07% Saham
Virtus Investment Advisers, LLC $328.644 18.258 0,07% Saham
MANUFACTURERS LIFE INSURANCE COMPANY, THE $319.590 17.755 0,07% Saham
BANK OF MONTREAL /CAN/ $247.806 13.767 0,05% Saham
MetLife Investment Management, LLC $230.040 12.780 0,05% Saham
Bank of New York Mellon Corp $224.892 12.494 0,05% Saham
BANK OF AMERICA CORP /DE/ $223.452 12.414 0,05% Saham
Persistent Asset Partners Ltd $197.424 10.968 0,04% Saham
XTX Topco Ltd $190.152 10.564 0,04% Saham
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $178.218 9.901 0,04% Saham
CITIGROUP INC $160.110 8.895 0,03% Saham
Invesco Ltd. $154.980 8.610 0,03% Saham
NEW YORK STATE COMMON RETIREMENT FUND $136.800 7.600 0,03% Saham
BlackRock, Inc. $119.484 6.638 0,03% Saham
Police & Firemen's Retirement System of New Jersey $114.642 6.369 0,02% Saham
WELLINGTON MANAGEMENT GROUP LLP $84.600 4.700 0,02% Saham
NORTHERN TRUST CORP $61.128 3.396 0,01% Saham
BNP PARIBAS FINANCIAL MARKETS $59.454 3.303 0,01% Saham
MARSHALL WACE, LLP $59.130 3.285 0,01% Saham
BARCLAYS PLC $54.648 3.036 0,01% Saham
Vanguard Global Advisers, LLC $48.852 2.714 0,01% Saham
Legal & General Group Plc $37.746 2.097 0,01% Saham
Tower Research Capital LLC (TRC) $31.500 1.750 0,01% Saham
Russell Investments Group, Ltd. $31.068 1.726 0,01% Saham
ROYAL BANK OF CANADA $12.000 661 0,00% Saham
US BANCORP \DE\ $7.254 403 0,00% Saham
Parallel Advisors, LLC $4.752 264 0,00% Saham
PRICE T ROWE ASSOCIATES INC /MD/ $4.488 249.312 0,00% Saham
Allworth Financial LP $2.898 161 0,00% Saham
Sterling Capital Management LLC $1.368 76 0,00% Saham
SBI Securities Co., Ltd. $1.224 68 0,00% Saham
JPMORGAN CHASE & CO $1.206 67 0,00% Saham
MERCER GLOBAL ADVISORS INC /ADV $900 50 0,00% Saham
MORGAN STANLEY $792 44 0,00% Saham
Fortitude Family Office, LLC $720 40 0,00% Saham
Quarry LP $522 29 0,00% Saham
OSAIC HOLDINGS, INC. $468 26 0,00% Saham
Caitong International Asset Management Co., Ltd $378 21 0,00% Saham
NATIONAL BANK OF CANADA /FI/ $54 3 0,00% Saham

Orang dalam perusahaan 33 orang dalam · 15 pejabat · 18 direktur

Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Joshua T Brumm Chief Executive Officer 22 Juni 2026 S 281.212 0 1 $-761.067
Harout Semerjian Chief Executive Officer 12 Jan. 2024 A 25.000 0 0 $0
Richard William Scalzo Chief Financial Officer 22 Juni 2026 S 20.298 0 1 $-20.005
Brian M. Hahn SVP Finance, CFO 12 Jan. 2024 A 53.143 0 0 $0
Jonathan Mcneill President and COO 22 Juni 2026 S 139.158 0 1 $-369.677
Jan Pinkas Chief Scientific Officer 22 Juni 2026 S 22.239 0 1 $-23.171
Barbara Harlin Bispham General Counsel and Corporate Secretary. 22 Juni 2026 S 19.330 0 1 $-21.912
Ellie Eunkyung Im Chief Medical Officer 22 Juni 2026 S 22.069 0 1 $-21.930
Ryan Lynch Treasurer, Senior Vice President of Finance and Chief Accounting Officer. 22 Juni 2026 S 13.871 0 1 $-8.365
Bruce S Johnson SVP & Chief Commercial Officer 12 Jan. 2024 A 138.980 0 0 $0
Chinmaya Rath SVP and Chief Business Officer 12 Jan. 2024 A 0 0 $0
Edwin Rock Chief Medical Officer 12 Jan. 2024 A 375.403 0 0 $0
Armand Girard SVP, Chief Business Officer 11 Nov. 2022 P 29.161 0 0 $0
John L. Magnani SVP of Research, CSO 11 Nov. 2022 P 366.078 0 0 $0
Helen M. Thackray SVP Clinical Development, CMO 20 Jan. 2021 A 183.115 0 0 $0
Alexandra Balcom Direktur 2 Juni 2026 A 0 0 $0
Susan Moran Direktur 2 Juni 2026 A 0 0 $0
Jonathan Violin Direktur 2 Juni 2026 A 0 0 $0
David Charles Lubner Direktur 2 Juni 2026 A 0 0 $0
Rachel K. King Direktur 29 Des. 2023 A 511.860 0 0 $0
Mark Alan Goldberg Direktur 29 Des. 2023 A 20.244 0 0 $0
Patricia S Andrews Direktur 29 Des. 2023 A 58.608 0 0 $0
Scott Koenig Direktur 1 Juni 2023 M 36.750 0 0 $0
Scott Thomas Jackson Direktur 19 Mei 2023 A 5.250 0 0 $0
Timothy R Pearson Direktur 19 Mei 2023 A 24.650 0 0 $0
JUNIUS DANIEL M Direktur 19 Mei 2023 A 93.250 0 0 $0
James M Barrett Direktur 18 Mei 2018 A 4.995.664 0 0 $0
John J. Baldwin Direktur 29 Juni 2016 M 1.210 0 0 $0
Franklin H Top JR Direktur 17 Mei 2016 A 12.294 0 0 $0
Michael A Henos Direktur 15 Juli 2015 A 469.454 0 0 $0
William M. Gust Direktur 15 Jan. 2014 C 409.947 0 0 $0
Scott D. Sandell Pemilik 10% 26 Jan. 2023 S 2.237.196 0 0 $0
Peter J Barris Pemilik 10% 10 Mei 2018 X 4.995.664 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Aktivis & pemilik 5%+ 4 saham

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 pengajuan 20 Juli 2026 16,52% Amandemen Investasi pasif SEC
Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 pengajuan 20 Juni 2025 0,37% Amandemen SEC
8 Mei 2024 Pengajuan awal SEC
New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 pengajuan 29 Feb. 2024 Pengajuan awal SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Kepemilikan ETF Dimiliki oleh 10 ETF

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
IWC · iShares Trust 0,08% 73.362 SH 8 Agu 2026 Harian
IWO · iShares Trust 0,02% 197.875 SH 8 Agu 2026 Harian
VTWG · VANGUARD SCOTTSDALE FUNDS 0,02% 23.282 SH 8 Agu 2026 Harian
AVSC · AMERICAN CENTURY ETF TRUST 0,01% 15.612 NS 31 Mei 2026 N-PORT
IWM · iShares Trust 0,01% 529.441 SH 8 Agu 2026 Harian
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 124.281 SH 8 Agu 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,00% 83.801 SH 8 Agu 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,00% 661.946 SH 8 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 1.832 SH 8 Agu 2026 Harian
VHT · VANGUARD WORLD FUND 0,00% 39.408 SH 8 Agu 2026 Harian